Swedish Orphan Biovitrum AB (B6E) Q2 2023 Earnings Report
DE:B6E Q2 2023 EPS Results
- Actual EPS
- EUR 0.13
- Consensus EPS
- EUR 0.09
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- EUR 0.08
DE:B6E Q2 2023 Revenue Results
- Actual Revenue
- EUR 443.00M
- Expected Revenue
- EUR 402.16M
- Beat/Miss
- Beat by +EUR 40.84M
- YoY Revenue Growth
- +25.70%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 07/18/2023
- Time
- Before Open
- Conference Call
- Tuesday, July 18, 2023
DE:B6E Upcoming Earnings
Swedish Orphan Biovitrum AB's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B6E Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 0.60- | 0.49 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 0.550.61 | -0.76 | 180.41% (+1.36) | |
| Jul 16, 2026 | 2026 (Q2) | 0.310.29 | 0.17 | 71.58% (+0.12) | |
| Apr 28, 2026 | 2026 (Q1) | 0.330.35 | 0.23 | 49.41% (+0.11) | |
| Feb 05, 2026 | 2025 (Q4) | 0.380.49 | 0.37 | 32.43% (+0.12) | |
| Oct 20, 2025 | 2025 (Q3) | 0.42-0.76 | 0.39 | -294.85% (-1.14) | |
| Jul 16, 2025 | 2025 (Q2) | 0.150.17 | 0.06 | 177.27% (+0.11) | |
| Apr 29, 2025 | 2025 (Q1) | 0.200.23 | 0.21 | 8.51% (+0.02) | |
| Feb 05, 2025 | 2024 (Q4) | 0.330.37 | 0.27 | 34.77% (+0.10) | |
| Oct 24, 2024 | 2024 (Q3) | 0.200.39 | 0.05 | 690.74% (+0.34) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
